Literature DB >> 1959769

Are double-blind food challenges necessary before starting an elimination diet?

E A Pastorello1, V Pravettoni, L Stocchi, A Bigi, M L Schilke, C Zanussi.   

Abstract

Food allergy is normally treated by eliminating the offending food. Such a measure, however, may cause nutritional and sociopsychological problems, so an allergy must be diagnosed with the utmost certainty. To date the most reliable diagnostic test is the double-blind food challenge (DBFC). The rationale for using this test is the marked difference in positive results with open and double-blind food challenges. Only about 30% of open challenges that appear positive are confirmed on blind challenge. There is ample evidence, too, that a negative DBFC may in fact indicate tolerance to that food. From the literature it appears that almost all patients who reintroduced a certain food into their diet after a DBFC had given negative findings did not present any adverse reaction to it. In our caselist of 21 patients with probable reactions to foods but negative DBFC, 19 (90.5%) tolerated the "incriminated" food well when it was reintroduced into their diet even in unlimited amounts. Only two (9.5%) again presented symptoms when they started taking large amounts of the problem food. Therefore, one precaution recommended before reintroducing a food item into a patient's diet after a negative DBFC is to check how it is tolerated at high doses. A review of the literature confirms the unquestioned utility of the DBFC. Nevertheless, in some situations this test is not indicated. The main one, of course, is in patients with life-threatening symptoms such as anaphylactic shock or glottis edema, in whom any provocation test is contraindicated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1959769     DOI: 10.2500/108854191778879089

Source DB:  PubMed          Journal:  Allergy Proc        ISSN: 1046-9354


  1 in total

1.  Eliciting dose is associated with tolerance development in peanut and cow's milk allergic children.

Authors:  C Nitsche; C D Westerlaken-van Ginkel; B J Kollen; A B Sprikkelman; G H Koppelman; A E J Dubois
Journal:  Clin Transl Allergy       Date:  2019-11-06       Impact factor: 5.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.